In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

UCB buys Celltech for £1.53bn in cash

Executive Summary

In the largest biotech transaction so far this year, UCB SA has agreed to acquire the approximately 278mm common shares of Celltech Group PLC for £1.53bn ($2.7bn) in cash, or almost six times the company's 2003 sales. Analysts say the merged biopharmaceutical company will rank fifth in sales volume worldwide--following behind Amgen, Novo Nordisk, Schering AG, and Genentech.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies